Therapath Partners LLC

Therapath Partners LLC is a specialized medical testing services provider that primarily supports the Department of Veterans Affairs (VA) and Defense Health Agency (DHA) with neuropathology testing and supplies. As a subsidiary of Inform Diagnostics, Inc., Therapath focuses on delivering critical diagnostic services, including nerve fiber analysis and specialized medical testing, to support healthcare for veterans. The company has been registered to receive federal awards since February 2018 and is structured as a for-profit limited liability company.

Through its federal contract awards, Therapath Partners LLC has consistently provided neuropathology testing services and associated supplies to various VA medical centers across different Veterans Integrated Service Networks (VISNs). The company has received multiple firm-fixed-price delivery orders and purchase orders from VISN 2, VISN 8, VISN 9, and VISN 10, with contract values ranging from $1,454.05 to $248,466.60. These awards have supported VA healthcare facilities in locations such as Lyons, New Jersey; Detroit, Michigan; Orlando, Florida; and East Orange, New Jersey. Additionally, Therapath has been awarded a $426,770 purchase order from the Defense Health Agency for nerve fiber testing services. Notably, none of Therapath's federal contract awards have utilized set-aside designations, as the company's specialized services are procured to meet critical healthcare needs for veterans.

Therapath Partners LLC holds two significant Indefinite Delivery Contracts (IDCs) with the Department of Veterans Affairs. The first IDC (36C24222D0045), awarded by VISN 2, has a ceiling value of $767,346 and supports neuropathology testing and supply services for the New Jersey VA Healthcare System through March 2024. Under this IDC, two firm-fixed-price delivery orders totaling $240,635 have been issued for services at the East Orange, New Jersey medical center. The second IDC (36C24821D0062), awarded by VISN 8, has a ceiling value of $248,466.60 and provides neuropathology testing services to facilities in Orlando, Florida. This contract has generated three firm-fixed-price delivery orders with a combined value of approximately $721,000. Both IDCs are single-award contracts without set-aside designations, allowing Therapath to consistently deliver specialized diagnostic services to support comprehensive medical care for veterans across multiple budget years.